The development of fatigue has been an area of interest to athletes and scientists alike for many years. Often, particularly during prolonged exercise in the heat, there is no obvious peripheral reason for fatigue and the central nervous system is cited as the source. The mechanisms and potential manipulations of this fatigue remain largely unclear. Chapters Three and Four attempted to reduce the transport of the serotonin precursor tryptophan into the brain in order to reduce or delay serotonin synthesis and therefore increase exercise capacity. In Chapter Three branched-chain amino acid drinks were fed before and during prolonged cycling to exhaustion in the heat on two occasions and control drinks were fed on two other occasions. There was no effect of the branched-chain amino acids on exercise capacity and the intra-individual variability in seven of the eight participants was small. One participant did appear to cycle for longer on the branched-chain amino acid trials compared to the control trials. In Chapter Four a 104 g bolus of amino acids, designed to deplete plasma tryptophan concentration, was fed seven hours before a prolonged cycle to exhaustion in the heat. There was no difference in exercise capacity between the tryptophan depletion trial and the control trial in which tryptophan was also ingested. These findings suggest that the delivery of tryptophan to the central nervous system is not the only factor influencing the onset of fatigue. The investigation undertaken in Chapter Five looked at the serotonin transporter density on the blood platelets of current and retired international level athletes competing in either endurance or sprint running events and a sedentary control group. Using the platelet as an accessible and reliable model for the serotonergic neuron, the maximum number of binding sites was assessed using the radio-labelled serotonin reuptake inhibitor [3H]Paroxetine. Those currently training for endurance events had a greater number of binding sites than any of the other groups. This supports previous findings and suggests that endurance training can increase the number of serotonin transporters on blood platelet membranes. During resting heat exposure in Chapter Six, the application of a 1 % menthol solution to the skin of the forearms, back and forehead elicited a warming sensation in some individuals and a cooling sensation in other individuals, but never any change in skin or core temperature nor skin blood flow. A small proportion of individuals did not perceive any change in skin thermal sensation. Chapter Seven applied these findings to a pre-loaded twenty minute exercise performance test in the heat. It was hypothesised that those who perceived a warming effect may perform worse when a menthol solution was applied compared to a control solution and conversely, those who perceived a cooling sensation may perform better with a menthol solution than with a control solution. There was no difference in exercise performance between those who felt a warming sensation and those who felt a cooling sensation. Those who felt a warming sensation felt significantly warmer on the menthol trial than the control trial but this did not affect their performance. However, those who reported a cooling sensation tended to feel cooler on the menthol trial than the control trial, and there was a tendency for an improvement in performance on the menthol trial compared to the control trial. Due to the experimental protocols adopted in this thesis it was possible to assess the reliability of an exercise capacity test compared to an exercise performance test. Chapter Three showed a coefficient of variation of 11.0 ± 11.2 % and Chapter Four showed a 11.5 ± 12.4 % variability for exercise capacity tests. Chapter Seven showed a coefficient of variation in a pre-loaded time-trial exercise performance test of 3.9 ± 9.6 % suggesting that an exercise performance test may be more reliable than an exercise capacity test. However, the aims of an investigation are still likely to be the main factor influencing the choice of protocol. It seems likely that no single mechanism will be responsible for the cessation of exercise. The investigations undertaken in this thesis also highlight many avenues for future exploration.

Serotonin (5-HT) has long been implicated in the pathophysiology of depression and anxiety, and the therapeutic effect of treatments. Several drugs useful in treatment produce either acute or neuroadaptive changes in 5-HT_2C receptor activity, and there has been growing interest in how alterations in the 5-HT_2C receptor might be important in mediating antidepressant and anxiolytic activity. The neuropsychological hypothesis of drug action implies that the clinical effects of medications active in anxiety and depression are best understood through the effects of these agents on the processing of emotional information. Thus far, however, there has been no systematic attempt to identify the role of the 5-HT_2C receptor in drug-induced changes in emotional processing in humans. The current research therefore investigated the effects of drug treatments with 5-HT_2C blocking properties on neural and behavioural responses to emotional information in healthy volunteers. An fMRI study demonstrated that a single dose of mirtazapine, an antidepressant with action at the 5-HT_2C receptor, reduces activation in regions important in emotional processing, such as the amygdala and the fusiform gyrus, to threat-relevant stimuli. A series of behavioural studies utilized drugs acting, at least in part, as 5-HT_2C antagonists and agonists to show that these drugs are able to alter emotional processing, particularly emotional memory. A seven-day administration of mirtazapine was shown to increase the recall of positive versus negative personality characteristics. A single dose of agomelatine, also an antidepressant with putative action at the 5-HT_2C receptor, did not increase slow wave sleep, suggesting, the drug had no effect of 5-HT_2C blockade in the brain. In Chapter 4, agomelatine and mCPP, a 5-HT_2C agonist, also shown to had no significant effect on emotional processing measures, but there was a statistical trend for agomelatine to increase memory for positive stimuli, and for mCPP to increase memory for negative stimuli. These findings suggest that antidepressants may work by altering the bias in emotional processing. Overall, the results of this exploration of the role of the 5-HT_2C receptor in emotional processing have contributed to the understanding of antidepressant treatment, and raise new possibilities for the continuation of study in this field.

G protein-coupled receptors (GPCRs) are seven-transmembrane domain receptors that sense extracellular signal and activate intracellular signaling pathways. The serotonin 5HT2A receptor (or 2AR) is one of the GPCRs coupled to Gq proteins, activating PLC and hydrolyzing PIP2. This hydrolysis causes a diffusion of bound PIP2 away from the channel binding site resulting in G protein-gated inwardly rectifying K+ channel (GIRK) inhibition and a downstream stimulation of Ca2+ release from endoplasmic reticulum stores. Previous experiments have demonstrated that the serotonin 5HTA receptor is a target of serotonergic psychedelic drugs, such as LSD, and partially mediates the action of many atypical antipsychotic drugs. However, the portion responsible for the functional activity and response of these drugs is unknown. The purpose of this study was to functionally characterize four deconstructed analogs of risperidone, an atypical antipsychotic agent, using two assays: by application to 5HT2A receptors in Xenopus oocytes and by calcium epifluorescence imaging in a HEK293 cell line stably expressing 2AR. Our experiments revealed that two analogs, RHV-006 and RHV-008, are partial agonists by themselves and greatly antagonize the effects of serotonin. RHV-006 and RHV-008 contain the piperidine and benzisoxizole ring systems of risperidone. RHV-023 and RHV-026, on the other hand, are more efficacious agonists than RHV-006 and RHV-008 but display a non-antagonistic effect with serotonin. RHV-023 and RHV-026 contain both the piperidine and benzisoxizole ring systems in addition to part of the diazabicyclo ring, thus containing more of risperidone’s structure than RHV-006 and RHV-008.

Pharmaceuticals that end up in our aquatic environment continue to increase. In recent years, serotonin re-uptake inhibitors (SSRI) have increased in usage as it is considered safer than other substances to treat depression.  Fluoxetine (Prozac) is a widely used anti-depressant that commonly leak out after human use to aquatic environments. Although widely spread, the impact of fluoxetine on aquatic animals in is poorly investigated. The objective of this study was to see if fluoxetine impacts the behaviour of freshwater isopod Asellus aquaticus. Asellus aquaticus were exposed to an ecologically relevant concentration of fluoxetine for 28 days. Through a series of behavioural assays designed to measure the personality traits boldness, activity, exploration and escape behaviour, Asellus aquaticus responses were investigated. A. aquaticus can differ greatly in phenotype, from non-pigmentation to dark pigmentation. Further objective was therefore to investigate if pigmentation correlated with any of the measured behavioural responses, due to potential across-reaction between serotonergic and melatoneric systems. I found that fluoxetine reduced boldness, but had no effect on activity, exploration or escape behaviour. Furthermore, I observed no correlation between pigmentation and behaviour measured in fluoxetine exposed, or control animals. These results indicate that fluoxetine at low levels  affect boldness of wild A. aquaticus but no other personality traits explored. However, other research contradicts these results and show that fluoxetine can affect a range of behaviours. Taken together fluoxetine can have ecological impact on aquatic environments. Hence, our residual pharmaceuticals can have ranging effects.

Circadian rhythms are ubiquitous among organisms, influencing a wide array of physiological processes and behaviors including aggression. While many neurophysiological mechanisms are involved in the regulation of aggressive behaviors, relatively few studies have investigated the underlying components involved in the interplay between circadian rhythms and aggression. Spiders are an ideal model system for studying circadian regulation of aggression as they are ecologically both predators and prey. Recent studies have revealed a nocturnal orb- weaving spider Larinioides cornutus exhibits a diel and circadian rhythm in anti-predator behavior (i.e. boldness) that can be manipulated by administration of octopamine (OA) and serotonin (5- HT). Dosing of OA increases boldness of an individual while 5-HT decreases boldness levels. Thus, it appears the serotonergic and octopaminergic system are playing a key role in the daily fluctuations of boldness. This study took a holistic approach to investigate OA and 5-HT levels of head tissue and hemolymph (i.e. blood) as well as the genes involved in synthesis, signaling, and degradation of these monoamines throughout the day (0100, 0700, 1300, and 1900 hours) using HPLC-ED and RNA-sequencing. Although endogenous and circulating levels of OA did not significantly fluctuate, putative transcripts involved in synthesis and signaling did increase in relative expression levels at dusk when L. cornutus begins to actively forage for prey. Endogenous and circulating levels of 5-HT also did not significantly change at the four different time points, but clear patterns of upregulation of 5-HT synthesis enzymes as well as some receptor transcripts were upregulated during the day when L. cornutus would be mostly inactive in its retreat. Lastly, monoamine oxidase, a major catabolic enzyme of monoamines in vertebrates and some invertebrates, was identified in L. cornutus and exhibited substrate specificity for OA compared to 5-HT. Together with the higher enzymatic activity at mid-day compared to dusk, MAO appears to be playing a significant role in regulating the OA and 5-HT signaling in L. cornutus. In conclusion, these results allow a unique preliminary perspective on how OA and 5-HT are influencing the diel shifts in aggression-related behaviors in an ecologically dynamic arthropod.

Variationen im Gen der Tryptophanhydroxylase 2 (TPH2), das den geschwindigkeitsbestimmenden Schritt der Serotoninsynthese katalysiert, wurden mit psychiatrischen Erkrankungen, die durch emotionale Dysregulation charakterisiert sind, in Verbindung gebracht. Die vorliegende Arbeit evaluierte die Rolle von TPH2 Varianten und Haplotypen bei Persönlichkeitsstörungen der Cluster B und C. Dazu wurden 420 Patienten mit Cluster B oder Cluster C Persönlichkeitsstörung (nach DSM-IV-TR) sowie 336 gesunde Probanden als Kontrollgruppe bezüglich TPH2 SNPs (rs4570625, rs11178997, rs4341581, rs4565946) genotypisiert. Die Persönlichkeitsstörungen wurden mit Hilfe des „Strukturierten Klinischen Interviews für DSM-IV-TR, Achse II“ (SKID-II) diagnostiziert und in die Cluster A, B und C eingeteilt. Die vorliegenden Resultate verknüpfen potentiell funktionelle TPH2 Varianten – insbesondere den rs4570625 SNP – mit Cluster B und Cluster C Persönlichkeitsstörungen. Für beide Patientengruppen zeigte sich eine signifikante globale Assoziation. Das T-Allel von rs4570625 war sowohl mit Cluster B als auch Cluster C Persönlichkeitsstörungen signifikant assoziiert. Diese Ergebnisse bestätigen TPH2 als ein Suszeptibilitäts- und/oder Modifier-Gen von affektiven Spektrumsstörungen. Die Relevanz für die Ätiologie von adulten ADHS und dramatisch-emotionalen Cluster B beziehungsweise ängstlich-furchtsamen Cluster C Persönlichkeitsstörungen muss durch weitere Studien untersucht werden. / Variation in the tryptophan hydroxylase-2 gene (TPH2) coding for the rate-limiting enzyme of serotonin (5-HT) synthesis in the brain has been linked to a spectrum of clinical populations characterized by emotional dysregulation. Here, a set of common single nucleotide polymorphisms (SNPs) in and downstream of the transcriptional control region of TPH2 (rs4570625, rs11178997, rs4341581, rs4565946) was testet for association in two cohorts comprising of 336 healthy individuals and 420 patients with personality disorders. Personality disorders were diagnosed with the Structured Clinical Interview of DSM-IV and were allocated to clusters A, B, and C. Individual SNP and haplotype analyses revealed significant differences in genotype frequencies between controls and cluster B as well as cluster C patients, respectively. In both patient groups, overrepresentation of T allele carriers of a functional polymorphism in the upstream regulatory region of TPH2 (SNP G-703T, rs4570625) was observed. The results link potentially functional TPH2 variants to cluster B and cluster C personality disorders. These findings confirm TPH2 as a susceptibility and/or modifier gene of affective spectrum disorders. The relevance for the etiology of adult ADHD as well as Cluster B and Cluster C personality disorders needs further study.

Several lines of evidence implicate a dysregulation of tryptophan hydroxylase (TPH)-dependent serotonin (5-HT) synthesis in emotions and stress and point to their potential relevance to the etiology and pathogenesis of various neuropsychiatric disorders. However, the differential expression pattern of the two isoforms TPH1 and TPH2 which encode two forms of the rate-limiting enzyme of 5-HT synthesis is controversial. Here, a comprehensive spatio-temporal analysis clarifies TPH1 and TPH2 expression during pre- and postnatal development of the mouse brain and in adult human brain as well as in peripheral organs including the pineal gland. Four different methods (real time PCR, in situ hybridization, immunohistochemistry and Western blot analysis) were performed to systematically control for tissue-, species- and isoform-specific expression on both the pre- and posttranslational level. TPH2 expression was consistently detected in the raphe nuclei, as well as in fibres in the deep pineal gland and in the gastrointestinal tract. Although TPH1 expression was found in these peripheral tissues, no significant TPH1 expression was detected in the brain, neither during murine development, nor in mouse and human adult brain. Also under conditions like stress and clearing the tissue from blood cells, no changes in expression levels were detectable. Furthermore, the reuptake of 5-HT into the presynaptic neuron by the serotonin transporter (SERT) is the major mechanism terminating the neurotransmitter signal. Thus, mice with a deletion in the Sert gene (Sert KO mice) provide an adequate model for human affective disorders to study lifelong modified 5-HT homeostasis in interaction with stressful life events. To further explore the role of TPH isoforms, Tph1 and Tph2 expression was studied in the raphe nuclei of Sert deficient mice under normal conditions as well as following exposure to acute immobilization stress. Interestingly, no statistically significant changes in expression were detected. Moreover, in comparison to Tph2, no relevant Tph1 expression was detected in the brain independent from genotype, gender and treatment confirming expression in data from native animals. Raphe neurons of a brain-specific Tph2 conditional knockout (cKO) model were completely devoid of Tph2-positive neurons and consequently 5-HT in the brain, with no compensatory activation of Tph1 expression. In addition, a time-specific Tph2 inducible (i) KO mouse provides a brain-specific knockdown model during adult life, resulting in a highly reduced number of Tph2-positive cells and 5-HT in the brain. Intriguingly, expression studies detected no obvious alteration in expression of 5-HT system-associated genes in these brain-specific Tph2 knockout and knockdown models. The findings on the one hand confirm the specificity of Tph2 in brain 5-HT synthesis across the lifespan and on the other hand indicate that neither developmental nor adult Tph2-dependent 5-HT synthesis is required for normal formation of the serotonergic system, although Tph1 does not compensate for the lack of 5-HT in the brain of Tph2 KO models. A further aim of this thesis was to investigate the expression of the neuropeptide oxytocin, which is primarily produced in the hypothalamus and released for instance in response to stimulation of 5-HT and selective serotonin reuptake inhibitors (SSRIs). Oxytocin acts as a neuromodulator within the central nervous system (CNS) and is critically involved in mediating pain modulation, anxiolytic-like effects and decrease of stress response, thereby reducing the risk for emotional disorders. In this study, the expression levels of oxytocin in different brain regions of interest (cortex, hippocampus, amygdala, hypothalamus and raphe nuclei) from female and male wildtype (WT) and Sert KO mice with or without exposure to acute immobilization stress were investigated. Results showed significantly higher expression levels of oxytocin in brain regions which are involved in the regulation of emotional stimuli (amygdala and hippocampus) of stressed male WT mice, whereas male Sert KO as well as female WT and Sert KO mice lack these stress-induced changes. These findings are in accordance with the hypothesis of oxytocin being necessary for protection against stress, depressive mood and anxiety but suggest gender-dependent differences. The lack of altered oxytocin expression in Sert KO mice also indicates a modulation of the oxytocin response by the serotonergic system and provides novel research perspectives with respect to altered response of Sert KO mice to stress and anxiety inducing stimuli. / Durch zahlreiche Untersuchungen ist belegt, dass eine gestörte Tryptophan-Hydroxylase (TPH)-abhängige Serotonin (5-HT)-Synthese an einer veränderten emotionalen Reaktion sowie einer veränderten Stress-Antwort beteiligt ist und damit auch in der Ätiologie und Pathogenese psychischer Erkrankungen eine Rolle spielt. Dennoch werden nach wie vor die unterschiedlichen Expressionsmuster der beiden Isoformen TPH1 und TPH2, die für zwei Formen des Schrittmacherenzyms der 5-HT-Synthese kodieren, kontrovers diskutiert. Zentrales Anliegen dieser Arbeit ist daher eine Klärung der TPH1- und TPH2-Expression während der prä- und postnatalen Entwicklung des murinen Gehirns, sowie im adulten humanen Gehirn und in einigen peripheren Organen und der Zirbeldrüse. Durch die Verwendung von vier verschiedenen Methoden (Real time-PCR, In situ-Hybridisierung, Immunhistochemie und Westernblot-Analysen) wurde systematisch die Gewebs- und Isoform-spezifische Expression in Maus und Mensch auf prä- und posttranslationaler Ebene nachgewiesen. TPH2-Expression wurde Spezies-übergreifend in den Raphe-Kernen des Hirnstamms wie auch in Fasern zur Zirbeldrüse und im Gastrointestinaltrakt detektiert. Auch TPH1 konnte in diesen peripheren Organen (die Zirbeldrüse eingeschlossen) nachgewiesen werden, jedoch fand sich keine signifikante TPH1-Expression im Gehirn, weder während der Entwicklung des Maus-Gehirns noch im humanen und murinen adulten Gehirn. Auch durch veränderte Bedingungen wie der Entfernung von Blutzellen aus dem Gewebe oder der Anwendung von akutem Immobilisierungsstress konnte keine Änderung der Expression gemessen werden. Sert Knockout-Mäuse, stellen ein geeignetes Tiermodell für affektive Erkrankungen dar, insbesondere um eine lebenslang veränderte 5-HT-Homöostase in Verbindung mit belastenden Lebensereignissen zu untersuchen. Um die Bedeutung der TPH-Isoformen und deren korrekte Expression weiter zu untersuchen, wurde die Tph1- und Tph2-Expression in den Raphe-Kernen von Sert Knockout (KO)-Mäusen unter normalen Bedingungen und nach akutem Stress getestet. Interessanterweise konnten keine statistisch signifikanten Expressionsänderungen entdeckt werden. Mehr noch, relativ zu Tph2 konnte unabhängig von Behandlung, Geschlecht oder Genotyp keine relevante Tph1-Expression im Gehirn gemessen werden, was wiederum die Expressionsdaten aus nativen Tieren unterstützt. Die Raphe-Neurone eines Gehirn-spezifischen konditionalen Tph2 KO-Modells zeigten weder Tph2-positive Zellen noch 5-HT, wiesen aber auch keine kompensatorische Aktivierung der Tph1-Expression im Gehirn auf. Zusätzlich repräsentiert eine zeit-spezifische, induzierbare KO-Maus ein Gehirn-spezifisches Tph2 Knockdown-Modell ab dem Erwachsenenalter, das eine stark reduzierte Anzahl an Tph2-positiven Zellen und 5-HT im Gehirn aufweist. Expressionsuntersuchungen zeigten interessanterweise, dass diese Gehirn-spezifischen Tph2 Knockout- und Knockdown-Modelle keine sichtliche Änderung in der Expression von 5-HT-System-assoziierten Genen aufweisen. Diese Ergebnisse bestätigen zum einen, dass die 5-HT-Synthese im murinen Gehirn während der kompletten Lebensspanne ausschließlich durch Tph2 katalysiert wird und weisen außerdem darauf hin, dass eine Tph2-abhängige 5-HT-Synthese weder während der Entwicklung noch im Erwachsenalter für die Ausbildung eines normalen serotonergen Systems benötigt wird, obwohl Tph1 den Verlust des 5-HT-Vorkommens im Gehirn der Tph2 KO-Mäuse nicht kompensiert. Weiterhin beschäftigt sich diese Arbeit mit der Expression von Oxytocin, das hauptsächlich im Hypothalamus produziert. Oxytocin ist maßgeblich bei Angst-lösenden Effekten sowie einer verringerten Stressantwort beteiligt. In dieser Studie wurde die Expression von Oxytocin in verschiedenen Gehirnregionen (Cortex, Hippocampus, Amygdala, Hypothalamus und Raphe Nuclei) von weiblichen und männlichen Wildtyp- (WT) und Sert KO-Mäusen getestet, die entweder unter normalen Bedingungen gehalten wurden oder eine Stunde lang akutem Immobilisierungsstress ausgesetzt waren. Die Ergebnisse zeigten eine signifikant höhere Oxytocin-Expression in Gehirnregionen, die für die emotionale Reizverarbeitung zuständig sind (Amygdala und Hippocampus) in gestressten männlichen WT-Mäusen, während männliche Sert KO-Mäuse sowie weibliche WT- und Sert KO-Mäuse diese Stress-bedingten Unterschiede nicht aufwiesen. Diese Befunde sind im Einklang mit der Hypothese, dass Oxytocin eine schützende Rolle bei Stress, depressiver Stimmung und Angst übernimmt, weisen jedoch auf einen Geschlechterunterschied hin. Ferner legt das Fehlen einer veränderten Oxytocin-Expression in Sert KO-Mäusen eine Modulation der Oxytocin-Expression durch das serotonerge System nahe, was neue Forschungsperspektiven über eine veränderte Reaktion auf Stress und Angst-auslösende Reize in Sert KO-Mäusen eröffnet.

Serotonin (5-HT) is an important modulator of many physiological, behavioural and developmental processes and it plays an important role in stress coping reactions. Anxiety disorders and depression are stress-related disorders and they are associated with a malfunction of the 5-HT system, in which the 5-HT transporter (5-HTT) plays an important role. 5-Htt knockout (KO) mice represent an artificially hyperserotonergic environment, show an increased anxiety-like behaviour and seem to be a good model to investigate the role of the 5-HT system concerning stress reactions and anxiety disorders. As synaptic proteins (SPs) seem to be involved in stress reactions, the effect of acute immobilization stress on the expression of the three SPs Synaptotagmin (Syt) I, Syt IV and Syntaxin (Stx) 1A was studied in the 5-Htt KO mouse model as well as the expression of the two immediate early genes (IEGs) FBJ osteosarcoma oncogene (c-Fos) and fos-like antigen 2 (Fra-2). Additionally, the expression of the corticotrophin releasing hormone (CRH) and its two receptors CRHR1 and CRHR2 was investigated as part of the hypothalamic-pituitary-adrenal (HPA) stress system. Based on gender- and genotype-dependent differences in corticosterone levels, expression differences in the brain were investigated by performing a quantitative real time-PCR study using primer pairs specific for these SPs and for the IEGs c-Fos and Fra-2 in five different brain regions in 5-Htt KO and 5-Htt wild-type (WT) mice. Mainly gender-dependent differences could be found and weaker stress effects on the expression of SPs could be demonstrated. Regarding the expression of IEGs, stress-, gender- and genotype-dependent differences were found mainly in the hypothalamus. Also in the hypothalamus, gender effects were found concerning the expression of CRH and its both receptors. Additionally, in a second study, male 5-Htt WT and male 5-Htt deficient mice were subjected to a resident-intruder-paradigm which stresses the animals through a loser experience. The morphological changes of neurons were subsequently analyzed in Golgi-Cox-stained sections of limbic brain areas in stressed and unstressed animals of both genotypes using the computer-based microscopy system Neurolucida (Microbrightfield, Inc.). While no differences concerning dendritic length, branching patterns and spine density were found in the hippocampus and no differences concerning dendritic length and branching patterns could be shown in the cingulate cortex (CG), pyramidal neurons in the infralimbic cortex (IL) of stressed 5-Htt WT mice displayed longer dendrites compared to unstressed 5-Htt WT mice. The results indicate that, although in this model drastic alterations of neuronal morphology are absent, subtle changes can be found in specific brain areas involved in stress- and anxiety-related behaviour which may represent neural substrates underlying behavioural phenomena. / Serotonin (5-HT) ist ein wichtiger Modulator vieler physiologischer, verhaltensbiologischer und entwicklungsbiologischer Vorgänge und spielt zudem eine wichtige Rolle bei der Stressbewältigung. Angsterkrankungen und Depression sind stressbedingte Störungen und sie sind mit einer Dysfunktion des serotonergen Systems assoziiert, in dem der Serotonintransporter (5-HTT) eine wichtige Funktion einnimmt. 5-Htt Knockout (KO)-Mäuse haben reduzierte Serotoninkonzentrationen im Gehirn, zeigen erhöhtes Angst-ähnliches Verhalten und scheinen ein gutes Modell für die Erforschung der Rolle des serotonergen Systems in Bezug auf Stress-Reaktionen und Angsterkrankungen darzustellen. Da synaptische Proteine (SPs) in die Stress-Reaktion involviert zu sein scheinen, wurden die Auswirkungen von akutem Immobilizierungsstress auf die Expression der drei SPs Synaptotagmin (Syt) I, Syt IV und Syntaxin (Stx) 1A in diesem 5-Htt KO-Maus-Modell untersucht. Ebenso wurde die Expression der zwei „immediate early genes“ (IEGs) FBJ osteosarcoma oncogene (c-Fos) and fos-like antigen 2 (Fra-2) unter die Lupe genommen. Außerdem wurde die Expression des „Corticotrophin Releasing Hormone“ (CRH) sowie seiner beiden Rezeptoren CRHR1 and CRHR2, als Teil des Hypothalamus- Hypophysen-Nebennieren-(HPA)-Systems, analysiert. Basierend auf Geschlechts- und Genotyp-spezifischen Unterschieden der Kortikosteron-Konzentrationen im Blut der Tiere wurden die Expressionslevel dieser SPs und der beiden IEGs mittels quantitativer Real-Time (qRT)-PCR in fünf verschiedenen Gehirnregionen von 5-Htt KO- und 5-Htt-Mäusen mit wildtypischer (WT) Gen-Konstitution untersucht. Dabei konnten vor allem Geschlechts-spezifische Unterschiede in der Genexpression gezeigt werden und es konnte ein im Vergleich dazu schwächerer Einfluss des akuten Immobilisierungs-Stresses auf die Genexpression nachgewiesen werden. Die Expression der IEGs wurde durch Stress, Geschlecht und Genotyp vor allem im Hypothalamus beeinflusst. Ebenfalls im Hypothalamus konnte der Einfluss des Geschlechts auf die Expression des CRH und seiner beiden Rezeptoren gezeigt werden. In einer zweiten Studie wurden männliche 5-Htt KO-Mäuse sowie 5-Htt WT-Mäuse dem „Resident-Intruder-Paradigma“ unterzogen, in welchem die Tiere mittels einer mehrfachen Verlierer-Erfahrung gestresst wurden. Morphologische Veränderungen von Neuronen limbischer Gehirnareale wurden daraufhin an Golgi-Cox-gefärbten Gehirnschnitten dieser gestressten und ungestressten 5-Htt KO- und 5-Htt WT-Tiere mittels des Computer-gestützten Mikroskop-Systems Neurolucida (Microbrightflield, Inc.) analysiert. Während keine Unterschiede bezüglich der Länge des dendritischen Materials, des Verzweigungsmusters und der Spinedichte im Hippocampus gefunden werden konnten und keine Unterschiede in Länge des dendritischen Materials und des Verzweigungsmusters in der Area cinguli (CG) gezeigt werden konnten, wiesen Pyramidenzellen im infralimbischen Kortex (IL) von gestressten 5-Htt WT-Mäusen längere Dendriten auf als die entsprechenden Zellen in den ungestressten Tieren desselben Genotyps. Diese Ergebnisse zeigen, dass, obwohl in diesen Tieren keine drastischen stressbedingten Änderungen der neuronalen Morphologie vorliegen, doch subtile Änderungen der neuronalen Morphologie stress- und angstinvolvierter Gehirnareale gefunden werden können. Diese Änderungen können die neuronale Basis verschiedenster Verhaltens-Phänomene darstellen.

Thesis advisor: John P. Christianson / Patients with posttraumatic stress disorder (PTSD) often show impaired ability to discriminate between “danger” and “safety” cues. Women are more than twice as likely to be diagnosed with PTSD as compared to men; however, translational research has largely relied on the use of male subjects despite evidence of sex differences in fear-motivated behaviors. Serotonergic activity, originating in the dorsal raphe nucleus (DRN) of the central nervous system (CNS), has been found to modulate fear discrimination in males and may contribute to sex differences observed in a Pavlovian fear discrimination paradigm. In this study, male and intact female Sprague-Dawley rats were exposed to fear conditioning with (CS+/CS-) or without (CS+) a safe conditioned stimulus, then subsequently sacrificed for immunohistochemical analysis of serotonergic activity via quantification of tryptophan hydroxylase (TPH) and Fos in the DRN. Females exhibited more rapid and robust discrimination between the CS+ danger cue and CS- safety cue as compared to males. Regardless of condition, females had more double-labeled TPH+Fos cells compared to males, but males had larger variation in TPH+Fos expression compared to females. A parabolic function for TPH+Fos counts predicted fear discrimination in males, but not females, reinforcing the view that serotonin is a modulator of safety-related behavior in males. / Thesis (BS) — Boston College, 2018. / Submitted to: Boston College. College of Arts and Sciences. / Discipline: Arts and Sciences Honors Program. / Discipline: Biology.

Analisamos o efeito do sistema serotoninérgico no desenvolvimento somático e na ontogênese de reflexos dos filhotes, cujas mães foram submetidas a tratamento farmacológico durante a prenhez. Ratas wistar prenhas foram divididas em dois grupos (N=11): Grupo AD, tratadas com água destilada, Grupo Sert, tratadas com sertralina 30mg/kg, 0,5mL/100g, s.c. Um dia após o parto 8 neonatos (4 machos e 4 fêmeas) foram mantidos com suas mães do 1º ao 21º dia pós-natal. O investigador cego avaliou o crescimento somático, características físicas e maturação de reflexos. Aos 22 e 60 dias de idade os encéfalos foram processados com técnicas de imunoistoquímica contra 5-HT. O grupo Sert, macho ou fêmea, apresentou atraso no crescimento somático e na maturação de alguns reflexos. A quantidade de neurônios 5-HT-IR foi alterada nos núcleos da rafe nos ratos aos 22 dias de idade, mas não aos 60 dias. A análise da morfometria dos neurônios 5-HT-IR, em ambas as idades estudadas, revelou alterações em sua forma. Os resultados deste estudo demonstram a ação inibitória da serotonina sobre o crescimento somático e desenvolvimento sensório-motor bem como alterações na quantidade e na forma dos neurônios 5-HT em ratos. / The aim of the present study was to investigate the effects of prenatal sertraline exposure on offspring in growth and somatic development and even in the maturation of reflex in rats. Female wistar rats were treated with sertraline (Sert, 30 mg/kg, 0,5 mL/100 g, s.c., N=11) or distilled water (Control, N=11) during the whole pregnancy. After the birth, 8 pups (4 males and 4 females) were kept in each litter during lactation. The blind investigator evaluated indicators of general body growth parameters, somatic maturation and ontogeny of reflex during the period of lactation. The central nervous system alterations were approached by 5-HT-IR using the ABC-DAB-Peroxidase techniques in animals at the 22st and 60st postnatal day. The Sert group, showed reduction on the somatic growth and on the maturation of reflexes. There was reduction in the amount of the 5-HT-IR neurons in the raphe nuclei at the 22st postnatal day, but did not change at the 60st. The morphometric analysis revealed alterations in the shape of these cells at the 22st and 60st postnatal day. An inhibitory action of the 5-HT on the somatic and sensory-motor growth in these rats was also observed. After the lactation period, the amount and shape of the 5-HT neurons were altered.